NightHawk Biosciences Inc (NHWK)

[StonewallPatriot]

Regarding: Moderna's promising vaccine candidate and HTBX's response-

March 16, 2020:
https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins

July 14, 2020:
https://www.nejm.org/doi/full/10.1056/NEJMoa2022483

July 15, 2020:

Congratulations to @moderna_tx on encouraging Phase 1 results for their #COVID19 vaccine. Our T-cell activating vaccine may be highly synergistic with their antibody-generating vaccine to provide an extra layer of T-cell protection for high-risk patients that need it most.

— NightHawk Biosciences (@NightHawk_Bio) July 15, 2020